Raghav Chari

Raghav Chari is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as Chief Business and Innovation Officer at Azurity Pharmaceuticals and as President and CEO of Manzara Therapeutics Inc. Since September 2018, Raghav has focused on transforming peptide therapeutics through innovative predictive technologies. Prior to these roles, Raghav held the position of Chief Innovation Officer at Covis Pharma, and founded Kaiper, LLC, where Raghav established a strong presence as a biotechnology and healthcare technology entrepreneur. Raghav's experience also includes significant roles at Dr. Reddy's Laboratories, NPS Pharmaceuticals, Synaptic Pharmaceuticals, and McKinsey & Company. Raghav Chari earned a PhD in Physics from Princeton University and a BS in Mathematics from Caltech.